X

See our webpage about the GA-map® product platform

Visit page

Skip to content

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Contact us

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Contact us

Press Releases

Minutes from the Extraordinary General Meeting

2023-11-20

Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam

2023-11-16

Notice of Extraordinary General Meeting 2023

2023-11-092023-11-06

Information avseende nyttjandeperiod av teckningsoptioner av serie TO 2 i Genetic Analysis AS

2023-11-03

Correction: Updated intended record date for the intended Subsequent Offering announced in press release, November 2, 2023

2023-11-03

Correction of press release regarding subsequent offer

Subscriptions received in separate tranche of previously announced directed share issue

2023-11-062023-11-03

Board member resigns at his request

2023-11-02

Interim report January – September 2023

2023-11-022023-11-02

Q3 2023 interim report for shareholders

Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding letter of intent for further investment as well as updated milestones

2023-11-022023-11-02

GA private placement letter of intent milestones

Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers

2023-10-252023-10-24

GA-map new product Discovery launch

Post navigation

Older posts

Newer posts

← Previous Page1 … Page7 Page8 Page9 … Page15 Next →

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Ulvenveien 80B
0581 Oslo, Norway

Open Google Maps

Connect

Navigate

© 2023 Genetic Analysis

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Contact us